Hyperplasia
MONDO:0005043An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.
Also known as: hyperplasia, hyperplastic
272 clinical trials for this condition and its sub-types, 5 tagged with Hyperplasia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Hyperplasia
-
Benign prostatic hyperplasia 225 trials
-
Atypical endometrial hyperplasia 28 trials
-
Atypical lobular breast hyperplasia 11 trials
-
Complex endometrial hyperplasia 3 trials
-
C-cell hyperplasia 0 trials
-
Adrenal medullary hyperplasia 0 trials
-
Focal epithelial hyperplasia 0 trials
-
Parathyroid hyperplasia 0 trials
-
Simple endometrial hyperplasia 0 trials
-
Urothelial hyperplasia 0 trials
2 sub-types
- Flat urothelial hyperplasia 0 trials
- Papillary urothelial hyperplasia 0 trials
-
Usual ductal breast hyperplasia 0 trials
-
Fish oil pills could help fight prostate cancer, new study hints
Disease control OngoingThis phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Rese…
Phase 2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Could a common diabetes drug stop oral cancer before it starts?
Prevention OngoingThis phase 2 trial tests whether metformin, a widely used diabetes drug, can prevent oral cancer in 26 people with precancerous mouth lesions (leukoplakia or erythroplakia). Participants take metformin by mouth, and researchers check if the lesions shrink or disappear. The goal i…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Prevention
Last updated Jun 28, 2026 00:00 UTC
-
Two drugs go Head-to-Head for easing enlarged prostate symptoms
Symptom relief CancelledResearchers are comparing two drugs, naftopidil and tamsulosin, to see which better eases urinary symptoms in men with benign prostatic hyperplasia, a non-cancerous enlargement of the prostate. The study enrolls men aged 50 and older who have moderate to severe urinary symptoms, …
Phase 3 • Sponsor: Apsen Farmaceutica S.A. • Aim: Symptom relief
Last updated Sep 11, 2026 00:00 UTC